title: Circulating tumor cells: utility for predicting response to anti-EGFR therapies?
authors.forename: Marielena
authors.initials: M
authors.lastname: Mata
authors.forename: Mitch
authors.initials: M
authors.lastname: Raponi
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D008991:Monitoring, Physiologic; D009369:Neoplasms / Q000188:drug therapy*; D009360:Neoplastic Cells, Circulating; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012680:Sensitivity and Specificity
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; C512478:EGFR protein, human; D066246:ErbB Receptors